ANZCTR search results

These search results are from the Australian New Zealand Clinical Trials Registry (ANZCTR).

You can narrow down the results using the filters

32712 results sorted by trial registration date.
  • Development of a Peer-support based Cardiac-Diabetes Self-Management Program: A study protocol

    People with cardiac disease who have type 2 diabetes have higher readmission rates (22%) than those without diabetes (6%) (Wu & Chang, 2008). Although self-management is an effective approach to achieve better health outcomes, there are no such programs specifically designed for patients with both conditions. Such programs need to be enhanced by user-friendly technology and supported by patient peers. This project aims to extend the development of a peer support based Cardiac-Diabetes Self-Management Program (CDSMP) by preparing a DVD to support persons' engagement in follow-up study.

  • Study of Lenalidomide Maintenance Versus Placebo in Responding Elderly Patients With Diffuse Large B cell Lymphoma (DLBCL) and Treated With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP)

    In patients between 60-80 years with diffuse large B cell lymphoma (DLBCL), the current standard treatment is R-CHOP chemotherapy (consisting of the drugs Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone). However the probability of being alive and free of lymphoma 5 years after diagnosis is only 54%. Lenalidomide is an immune system modulating drug that has anti-lymphoma properties demonstrated in smaller studies of patients with relapsed/refractory DLBCL. Given the high risk of relapsed DLBCL in this older patient population this study is aimed at determining whether Lenalidomide maintenance taken orally for 21 days every 4 weeks can safely reduce the risk of progression/relapse of DLBCL. Who is it for? This study is open to patients aged between 60 and 80 years and currently underoing R-CHOP combination therapy for diffuse large B-cell lymphoma. Trial details Participants will be randomised into one of two arms, (1) 25mg daily lenalidomide for 21 days of a 28 day cycle of maintenenace therapy for up to 26 cycles, or (2) a placebo instead of the active drug over the same period. The aim of the study is to reduce the risk of progression/relapse of DLBCL

  • Examining the effects of serotonin on perceptual awareness and attention.

    Binocular rivalry occurs when different stimuli are presented to the left and right eye simultaneously. Under these conditions the observer will consciously perceive only one of the two images at a time, with the respective dominance of the two images alternating every few seconds. A similar phenomenon is also observed in hearing. Previous studies have shown that the rate of alternation is affected by certain medications that affect the serotonin system. We will administer two such medications to healthy individuals to further investigate how the serotonin system is involved in perceptual rivalry. The main implications of this study relate to pure research and understanding the neural mechanisms underlying perception. There is currently no clinical aim for this study.

  • A study of below knee serial casting for calf contracture in ambulant boys with Duchenne muscular dystrophy.

    Duchenne muscular dystrophy is a progressive disorder which affects muscle strength in boys and results in the loss of the ability to walk between 9 and 13 years of age. Along with muscle weakness the boys often also experience muscle tightness, particularly in their calf muscles. This in turn causes them to walk on their toes, which makes standing and walking balance more precarious. Boys with DMD undertake physiotherapy prescribed stretching programs and use night splinting to address this muscle tightness but commonly these are not sufficient to overcome the muscle shortening. Surgical lengthening has been shown to have a beneficial effect on ankle contracture in boys with DMD. This is very invasive and has not been shown to be associated with any improvement in strength or function. Below knee serial casting is used in some overseas centres as a treatment option for calf shortening. This project aims to assess the effectiveness of below knee serial casting on the length of calf muscles and walking ability in boys with DMD. We hope to assess whether short periods of serial casting will maintain calf muscle length, improve gait, and maintain or improve motor function. The boy’s gait, muscle length and motor function will be assessed before and after serial casting and then at 3 monthly intervals for a twelve month period.

  • The effect of zoledronate on marrow fat in osteoporotic elderly patients who have suffered a minimal trauma fracture.

    This is a one year study to identify the effect of Zoledronate on marrow fat in patients who have suffered a minimal trauma fracture. Changes in marrow fat in femur and vertebrae will be quantified using CT and MRI images analised using an image analysis software (Tomovision).

  • ManUp Gladstone Project: an Internet and Mobile Phone Delivered Physical Activity and Nutrition Intervention.

    ManUp is a physical activity and healthy eating project for men and is conducted in the Gladstone region. In this project we will use the Internet to help men to achieve their physical activity and healthy eating goals and challenges.

  • A pilot clinical trial assessing the efficacy and safety of supplementation with a B complex vitamin to reduce the incidence of chemotherapy induced peripheral neuropathy in patients diagnosed with a malignancy.

    This study aims to determine whether vitamin B supplementation can reduce the incidence of chemotherapy induced peripheral neuropathy (nerve damage) in patients diagnosed with cancer. Who is it for? You can join this study if you have been recently diagnosed with cancer for which you have been prescribed chemotherapy treatment with the drug paclitaxel, vincristine or oxaliplatin. Trial details Participants will be randomly allocated to one of two groups. One group will take 2 capsules of vitamin B complex daily 1 week before chemotherapy treatment for 9 months. The other group will be given 2 capsules of a placebo (sugar capsule) to take daily for 9 months. Patients will be assessed at three timepoints over the study duration to evaluate neuropathy, quality of life, pain, and levels of vitamin B in the blood.

  • Healthy Volunteer Study to Determine the Safety and Tolerability of MT10109 (Clostridium Botulinum Toxin Type A) in Comparison to Botox(Registered Trademark)

    This study is designed to compare the safety and efficacy of the investigational drug MT10109, a new formulation of Clostridium Botulinum Toxin Type A compared to Botox (Registered trademark). Subjects will have a single injection of MT10109 injected into the Extensor Digitorum Brevis (EDB) muscle of one foot and an equivalent dosage of Botox injected into the other foot.

  • Supporting Treatment decisions to Optimise stroke Prevention in AF- the Stop-Stroke in AF tria (STOP-STROKE in AF trial).

    This study aims to improve GPs' management of atrial fibrillation to prevent stroke.

  • Walking for Exercise and Nutrition to prevent Diabetes for You (Wendy)

    The prevalence of Gestational Diabetes (GDM) in Australia is approximately 5%-8%, with up to one third of all parous women who develop type 2 diabetes having a previous history of GDM . Research to determine strategies to delay or prevent the development of or progression to diabetes is vital, particularly in population groups that are at higher risk, such as GDM, and obese women (BMI.>25). A pilot randomised controlled trial (RCT) conducted at Mater Mothers Hospital suggested that a post partum intervention designed to increase physical activity in women with previous GDM may be feasible. A recent study in the United States recruited women with recent GDM into an RCT where the control group received usual care and the intervention group received a web based pedometer program. Dietary intervention has been proven to increase probability of weight loss, so a strategy of combining both a pedometer and nutrition based program may prove to be more successful in long term improvement in a healthy lifestyle to prevent type 2 diabetes. The aim of this study is to develop long term statergies for women who develop GDM during their pregnancy and are overweight (BMI > 25) to improve their lifestyle to possibly prevent Type 2 diabetes. This randomised controlled trial is a pedometer - based inervention to encourage physical activity , combined with nutrition coaching, and will possibly result in an increased weight loss, improved insulin sensitivity and increased physical activity when compared with standard care. This project aims to take another step towards the larger scale issue of providing adequate, evidence based follow up care for women who develop GDM in their pregnancies.

Tags:
  • Finding clinical trials